Erleada (Apalutamide)
- Medicine Name: Erleada
- Generic Name: Apalutamide
- Dosage Form & Strength: Tablets: 60 mg
- Manufactured By: Janssen Pharmaceuticals, Inc.
Medical uses
Warning & Precautions
Documentation & Availability
Sourcing & Delivery
FAQ
Medical uses
Erleada is an androgen receptor inhibitor used for the treatment of patients with
- metastatic castration-sensitive prostate cancer (mCSPC).
- non-metastatic castration-resistant prostate cancer (nmCRPC).
Recommended Dosage: The recommended dosage of Erleada tablets is 240 mg (4 × 60 mg tablets) administered orally (by mouth) once daily. Take these tablets with or without food. Each tablet of Erleada should be swallowed whole.
Gonadotropin-releasing hormone (GnRH) analog can be received concurrently or patients should have had a bilateral orchiectomy.
In case of a greater than or equal to Grade-3 toxicity or an intolerable adverse reaction, hold dosing with Erleada until signs/symptoms improve to less than or equal to Grade-1 or original grade, then resume at the same dose or a decreased dose (180 mg or 120 mg), if warranted.
In the event of a missed daily dose, patients should take their normal Erleada dose as quickly as possible on the same day with a return to the normal schedule on the following day. Do not take extra pills to make up for the missed or skipped dose.
Warning & Precautions
- Ischemic cardiovascular events, including events leading to death, may occur in those receiving erleada 60 mg. Monitor for signs/symptoms of ischemic heart disease. Optimize management of cardiovascular risk factors, such as hypertension, dyslipidemia, or diabetes. Consider interruption of treatment for Grade-3/4 events.
- Fractures may occur in those receiving Erleada. Assess patients for fracture risk. Evaluate and manage patients who are at risk for fractures as per the established treatment guidelines and consider the bone-targeted agents.
- Falls may occur in those receiving apalutamide 60 mg tablets with high frequency in the elderly. Assess patients for fall risk. In a randomized study, falls occurred in those treated with this medicine compared to those treated with placebo. Falls were not linked with seizure or loss of consciousness.
- Seizure may occur in those receiving apalutamide. Permanently interrupt treatment in those who develop a seizure while on treatment. It is unspecified whether anti-epileptic drugs will prevent seizures with apalutamide. Patients are at risk of developing a seizure while receiving erleada 240 mg and of engaging in any kind of activity where sudden loss of consciousness could cause harm to themselves or others.
- Apalutamide can be hazardous to a developing fetus. Male patients with female partners of reproductive potential should use effective contraception during therapy and for 3 months after the final dose of Apalutamide. Male patients should use a condom while having sex with a pregnant woman.
Documentation & Availability
What documents are required to import ERLEADA to India?
ERLEADA (apalutamide) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Proof of Identity (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is ERLEADA available in India?
ERLEADA (apalutamide tablets) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability of Erleada in India (Mumbai, Pune, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, and Bangalore etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
ERLEADA can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of ERLEADA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Erleada 60 mg price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
Indian Pharma Network is able to source the ERLEADA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Erleada®?
Apalutamide is Generic Name for the trade name drug Erleada®.
What is the Manufacturer Name of Erleada®?
Erleada® is manufactured by Janssen Pharmaceuticals, Inc.
Where can I get Erleada® at the best price in India?
To get the best Erleada- apalutamide price, contact Indian Pharma Network (a WHO-GDP & ISO 9001:2008 authorized Company). A valid medical prescription is required while buying Erleada®.
Is Erleada® approved by the FDA?
Yes, Erleada® is approved by the FDA. Date of first/initial approval: February 14, 2018.
What is the dosage and form of Erleada® supplied?
Erleada® is supplied as apalutamide 60mg tablets for oral administration.
What are the most common side effects with Erleada®?
The most common side effects with Erleada® are: fatigue, hypertension, arthralgia, rash, decreased appetite, fall, hot flush, weight decreased, diarrhea, and fracture.
How much does Erleada® cost in India?
Erleada cost in India is less and can vary. To buy/procure this breast cancer medication authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Erleada®?
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15-30°C (59-86°F). Store in the original package. Do not discard desiccant. Protect this medicinal product from light and moisture.
Is it safe to buy Erleada® online from India?
Yes, You can buy Erleada online in India at the best price from Indian Pharma Network if Erleada® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Erleada®?
Click Here to download full Erleada prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.